nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoprofen—Azotaemia—Methotrexate—lymphatic system cancer	0.00577	0.00577	CcSEcCtD
Fenoprofen—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.00575	0.00575	CcSEcCtD
Fenoprofen—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00571	0.00571	CcSEcCtD
Fenoprofen—Renal failure—Fludarabine—lymphatic system cancer	0.00571	0.00571	CcSEcCtD
Fenoprofen—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00559	0.00559	CcSEcCtD
Fenoprofen—Haematuria—Fludarabine—lymphatic system cancer	0.00553	0.00553	CcSEcCtD
Fenoprofen—Anorexia—Mechlorethamine—lymphatic system cancer	0.00545	0.00545	CcSEcCtD
Fenoprofen—Alopecia—Teniposide—lymphatic system cancer	0.00524	0.00524	CcSEcCtD
Fenoprofen—Haemoglobin—Fludarabine—lymphatic system cancer	0.00524	0.00524	CcSEcCtD
Fenoprofen—Haemorrhage—Fludarabine—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Fenoprofen—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00497	0.00497	CcSEcCtD
Fenoprofen—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00493	0.00493	CcSEcCtD
Fenoprofen—Diplopia—Carmustine—lymphatic system cancer	0.00482	0.00482	CcSEcCtD
Fenoprofen—Gastrointestinal haemorrhage—Carmustine—lymphatic system cancer	0.00482	0.00482	CcSEcCtD
Fenoprofen—Alopecia—Fludarabine—lymphatic system cancer	0.0046	0.0046	CcSEcCtD
Fenoprofen—Pancytopenia—Bleomycin—lymphatic system cancer	0.00453	0.00453	CcSEcCtD
Fenoprofen—Gastrointestinal haemorrhage—Mitoxantrone—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Fenoprofen—Confusional state—Teniposide—lymphatic system cancer	0.00425	0.00425	CcSEcCtD
Fenoprofen—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00421	0.00421	CcSEcCtD
Fenoprofen—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00421	0.00421	CcSEcCtD
Fenoprofen—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Fenoprofen—Tachycardia—Teniposide—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Fenoprofen—Malaise—Fludarabine—lymphatic system cancer	0.00409	0.00409	CcSEcCtD
Fenoprofen—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Fenoprofen—Haematuria—Bleomycin—lymphatic system cancer	0.00406	0.00406	CcSEcCtD
Fenoprofen—Pruritus—Mechlorethamine—lymphatic system cancer	0.00404	0.00404	CcSEcCtD
Fenoprofen—Anorexia—Teniposide—lymphatic system cancer	0.00401	0.00401	CcSEcCtD
Fenoprofen—Pancytopenia—Carmustine—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Fenoprofen—Convulsion—Fludarabine—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Fenoprofen—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Fenoprofen—Haemoglobin—Bleomycin—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Fenoprofen—Haemorrhage—Bleomycin—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Fenoprofen—Discomfort—Fludarabine—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Fenoprofen—Pancytopenia—Vincristine—lymphatic system cancer	0.00378	0.00378	CcSEcCtD
Fenoprofen—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00377	0.00377	CcSEcCtD
Fenoprofen—Dyspnoea—Teniposide—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Fenoprofen—Confusional state—Fludarabine—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Fenoprofen—Dysuria—Vincristine—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Fenoprofen—Depression—Carmustine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Fenoprofen—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Fenoprofen—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Fenoprofen—Decreased appetite—Teniposide—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Fenoprofen—Renal failure—Carmustine—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Fenoprofen—Vomiting—Mechlorethamine—lymphatic system cancer	0.00363	0.00363	CcSEcCtD
Fenoprofen—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Fenoprofen—Rash—Mechlorethamine—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Fenoprofen—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Fenoprofen—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Fenoprofen—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Fenoprofen—Depression—Vincristine—lymphatic system cancer	0.00354	0.00354	CcSEcCtD
Fenoprofen—Anorexia—Fludarabine—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Fenoprofen—Feeling abnormal—Teniposide—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Fenoprofen—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Fenoprofen—Renal failure—Mitoxantrone—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Fenoprofen—Nausea—Mechlorethamine—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Fenoprofen—Alopecia—Bleomycin—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Fenoprofen—Jaundice—Mitoxantrone—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Fenoprofen—Haemoglobin—Carmustine—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Fenoprofen—Urticaria—Teniposide—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Fenoprofen—Oliguria—Methotrexate—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Fenoprofen—Haemorrhage—Carmustine—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Fenoprofen—Body temperature increased—Teniposide—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Fenoprofen—Abdominal pain—Teniposide—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Fenoprofen—Dyspnoea—Fludarabine—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Fenoprofen—Haematuria—Mitoxantrone—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Fenoprofen—Oedema peripheral—Carmustine—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Fenoprofen—Dyspepsia—Fludarabine—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Fenoprofen—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Fenoprofen—Decreased appetite—Fludarabine—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Fenoprofen—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Fenoprofen—Fatigue—Fludarabine—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Fenoprofen—Constipation—Fludarabine—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Fenoprofen—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Fenoprofen—Hypersensitivity—Teniposide—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Fenoprofen—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Fenoprofen—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Fenoprofen—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Fenoprofen—Asthenia—Teniposide—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Fenoprofen—Cystitis noninfective—Methotrexate—lymphatic system cancer	0.003	0.003	CcSEcCtD
Fenoprofen—Malaise—Bleomycin—lymphatic system cancer	0.003	0.003	CcSEcCtD
Fenoprofen—Pruritus—Teniposide—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Fenoprofen—Cystitis—Methotrexate—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Fenoprofen—Alopecia—Carmustine—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Fenoprofen—Body temperature increased—Fludarabine—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Fenoprofen—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Fenoprofen—Diarrhoea—Teniposide—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Fenoprofen—Alopecia—Vincristine—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Fenoprofen—Discomfort—Bleomycin—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Fenoprofen—Bladder pain—Methotrexate—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Fenoprofen—Alopecia—Mitoxantrone—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Fenoprofen—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Fenoprofen—Confusional state—Bleomycin—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Fenoprofen—Vision blurred—Carmustine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Fenoprofen—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Fenoprofen—Tremor—Carmustine—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Fenoprofen—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Fenoprofen—Vomiting—Teniposide—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Fenoprofen—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Fenoprofen—Asthenia—Fludarabine—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Fenoprofen—Rash—Teniposide—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Fenoprofen—Dermatitis—Teniposide—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Fenoprofen—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Fenoprofen—Headache—Teniposide—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Fenoprofen—Pruritus—Fludarabine—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Fenoprofen—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Fenoprofen—Anorexia—Bleomycin—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Fenoprofen—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Fenoprofen—Diarrhoea—Fludarabine—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Fenoprofen—Convulsion—Carmustine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Fenoprofen—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Fenoprofen—Nausea—Teniposide—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Fenoprofen—Malaise—Mitoxantrone—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Fenoprofen—Dyspnoea—Bleomycin—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Fenoprofen—Convulsion—Vincristine—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Fenoprofen—Confusional state—Carmustine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Fenoprofen—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Fenoprofen—Decreased appetite—Bleomycin—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Fenoprofen—Vomiting—Fludarabine—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Fenoprofen—Convulsion—Mitoxantrone—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Fenoprofen—Rash—Fludarabine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Fenoprofen—Dermatitis—Fludarabine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Fenoprofen—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Fenoprofen—Headache—Fludarabine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Fenoprofen—Tachycardia—Carmustine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Fenoprofen—Discomfort—Mitoxantrone—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Fenoprofen—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Fenoprofen—Anorexia—Carmustine—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Fenoprofen—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Fenoprofen—Confusional state—Mitoxantrone—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Fenoprofen—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Fenoprofen—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Fenoprofen—Nausea—Fludarabine—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Fenoprofen—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Fenoprofen—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Fenoprofen—Urticaria—Bleomycin—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Fenoprofen—Anorexia—Vincristine—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Fenoprofen—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Fenoprofen—Body temperature increased—Bleomycin—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Fenoprofen—Insomnia—Carmustine—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Fenoprofen—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Fenoprofen—Dyspnoea—Carmustine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Fenoprofen—Somnolence—Carmustine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Fenoprofen—Anorexia—Mitoxantrone—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Fenoprofen—Decreased appetite—Carmustine—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Fenoprofen—Insomnia—Vincristine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Fenoprofen—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Fenoprofen—Constipation—Carmustine—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Fenoprofen—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Fenoprofen—Hypersensitivity—Bleomycin—lymphatic system cancer	0.002	0.002	CcSEcCtD
Fenoprofen—Decreased appetite—Vincristine—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Fenoprofen—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Fenoprofen—Somnolence—Mitoxantrone—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Fenoprofen—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Fenoprofen—Feeling abnormal—Carmustine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Fenoprofen—Fatigue—Vincristine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Fenoprofen—Asthenia—Bleomycin—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Fenoprofen—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Fenoprofen—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Fenoprofen—Constipation—Vincristine—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Fenoprofen—Pruritus—Bleomycin—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Fenoprofen—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Fenoprofen—Fatigue—Mitoxantrone—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Fenoprofen—Pancreatitis—Methotrexate—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Fenoprofen—Constipation—Mitoxantrone—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Fenoprofen—Body temperature increased—Carmustine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Fenoprofen—Abdominal pain—Carmustine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Fenoprofen—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Fenoprofen—Pancytopenia—Methotrexate—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Fenoprofen—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Fenoprofen—Dysuria—Methotrexate—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Fenoprofen—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Fenoprofen—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Fenoprofen—Abdominal pain—Vincristine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Fenoprofen—Body temperature increased—Vincristine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Fenoprofen—Urticaria—Mitoxantrone—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Fenoprofen—Hypersensitivity—Carmustine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Fenoprofen—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Fenoprofen—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Fenoprofen—Vomiting—Bleomycin—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Fenoprofen—Depression—Methotrexate—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Fenoprofen—Rash—Bleomycin—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Fenoprofen—Dermatitis—Bleomycin—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Fenoprofen—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Fenoprofen—Asthenia—Carmustine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Fenoprofen—Renal failure—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Fenoprofen—Hypersensitivity—Vincristine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Fenoprofen—Haematuria—Methotrexate—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Fenoprofen—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Fenoprofen—Asthenia—Vincristine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Fenoprofen—Diarrhoea—Carmustine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Fenoprofen—Nausea—Bleomycin—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Fenoprofen—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Fenoprofen—Asthenia—Mitoxantrone—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Fenoprofen—Dizziness—Carmustine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Fenoprofen—Haemoglobin—Methotrexate—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Fenoprofen—Diarrhoea—Vincristine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Fenoprofen—Haemorrhage—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Fenoprofen—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Fenoprofen—Vomiting—Carmustine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Fenoprofen—Dizziness—Vincristine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Fenoprofen—Rash—Carmustine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Fenoprofen—Dermatitis—Carmustine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Fenoprofen—Headache—Carmustine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Fenoprofen—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Fenoprofen—Tinnitus—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Fenoprofen—Vomiting—Vincristine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Fenoprofen—Rash—Vincristine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Fenoprofen—Dermatitis—Vincristine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Fenoprofen—Headache—Vincristine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Fenoprofen—Nausea—Carmustine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Fenoprofen—Vomiting—Mitoxantrone—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Fenoprofen—Rash—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Fenoprofen—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Fenoprofen—Headache—Mitoxantrone—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Fenoprofen—Alopecia—Methotrexate—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Fenoprofen—Nausea—Vincristine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Fenoprofen—Dysgeusia—Methotrexate—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Fenoprofen—Nausea—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Fenoprofen—Vision blurred—Methotrexate—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Fenoprofen—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Fenoprofen—Malaise—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Fenoprofen—Convulsion—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Fenoprofen—Discomfort—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Fenoprofen—Confusional state—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Fenoprofen—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Fenoprofen—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Fenoprofen—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Fenoprofen—Anorexia—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Fenoprofen—Insomnia—Methotrexate—lymphatic system cancer	0.000993	0.000993	CcSEcCtD
Fenoprofen—Dyspnoea—Methotrexate—lymphatic system cancer	0.000978	0.000978	CcSEcCtD
Fenoprofen—Somnolence—Methotrexate—lymphatic system cancer	0.000976	0.000976	CcSEcCtD
Fenoprofen—Dyspepsia—Methotrexate—lymphatic system cancer	0.000966	0.000966	CcSEcCtD
Fenoprofen—Decreased appetite—Methotrexate—lymphatic system cancer	0.000954	0.000954	CcSEcCtD
Fenoprofen—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000947	0.000947	CcSEcCtD
Fenoprofen—Fatigue—Methotrexate—lymphatic system cancer	0.000946	0.000946	CcSEcCtD
Fenoprofen—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000904	0.000904	CcSEcCtD
Fenoprofen—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000897	0.000897	CcSEcCtD
Fenoprofen—Urticaria—Methotrexate—lymphatic system cancer	0.000872	0.000872	CcSEcCtD
Fenoprofen—Abdominal pain—Methotrexate—lymphatic system cancer	0.000868	0.000868	CcSEcCtD
Fenoprofen—Body temperature increased—Methotrexate—lymphatic system cancer	0.000868	0.000868	CcSEcCtD
Fenoprofen—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000809	0.000809	CcSEcCtD
Fenoprofen—Asthenia—Methotrexate—lymphatic system cancer	0.000787	0.000787	CcSEcCtD
Fenoprofen—Pruritus—Methotrexate—lymphatic system cancer	0.000776	0.000776	CcSEcCtD
Fenoprofen—Diarrhoea—Methotrexate—lymphatic system cancer	0.000751	0.000751	CcSEcCtD
Fenoprofen—Dizziness—Methotrexate—lymphatic system cancer	0.000726	0.000726	CcSEcCtD
Fenoprofen—Vomiting—Methotrexate—lymphatic system cancer	0.000698	0.000698	CcSEcCtD
Fenoprofen—Rash—Methotrexate—lymphatic system cancer	0.000692	0.000692	CcSEcCtD
Fenoprofen—Dermatitis—Methotrexate—lymphatic system cancer	0.000691	0.000691	CcSEcCtD
Fenoprofen—Headache—Methotrexate—lymphatic system cancer	0.000687	0.000687	CcSEcCtD
Fenoprofen—Nausea—Methotrexate—lymphatic system cancer	0.000652	0.000652	CcSEcCtD
